<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F2C20A8A-B31E-4A1B-8E74-EB1F2EC5A830"><gtr:id>F2C20A8A-B31E-4A1B-8E74-EB1F2EC5A830</gtr:id><gtr:firstName>Ming</gtr:firstName><gtr:surname>Lei</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/67AB754F-6C4C-4FE1-93FB-55E1DBC984B1"><gtr:id>67AB754F-6C4C-4FE1-93FB-55E1DBC984B1</gtr:id><gtr:firstName>Elizabeth</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Cartwright</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3B028277-AD2C-4D4D-A6BE-DE318B1679A4"><gtr:id>3B028277-AD2C-4D4D-A6BE-DE318B1679A4</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Austin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C93EEE7C-E578-4F4A-97A8-95989028F2ED"><gtr:id>C93EEE7C-E578-4F4A-97A8-95989028F2ED</gtr:id><gtr:firstName>Ludwig</gtr:firstName><gtr:surname>Neyses</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1002082"><gtr:id>FB611739-0C4A-4BC3-B315-9E7D5375C93F</gtr:id><gtr:title>A novel role for the plasma membrane calcium pump (PMCA1) in cardiomyopathy and blood pressure control</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002082</gtr:grantReference><gtr:abstractText>Heart failure affects around 1 million people in the UK, patient numbers are rising rapidly and survival is similar to that of some cancers. Heart failure patients are known to die from two main causes, either pump failure or heartbeat abnormalities (arrhythmias). In addition, high blood pressure (hypertension) greatly aggravates heart failure. 

Improving treatment of heart failure, which currently is highly unsatisfactory, is the main motivation for our research. We have shown that a gene called the plasma membrane calcium pump isoform 1 (PMCA1) is central to all three key features of heart failure ? pump failure, arrhythmias and hypertension. By transporting calcium out of the cell PMCA1 helps the heart muscle to relax and blood pressure to fall. Strongly supporting our approach, recent genetic studies in humans have shown that PMCA1 is key to human disease. Our programme will take these findings to the next essential level, i.e. understanding the function of PMCA1. To this end we will study mouse models in which the level of PMCA1 in the heart and vessels has been genetically modified. This programme is pivotal for understanding heart failure and hypertension and will provide information essential to the development of new treatments.</gtr:abstractText><gtr:technicalSummary>Heart failure (HF) currently affects around 1 million people in the UK leading to an annual financial burden on the health services of over #1 billion, and its incidence is rising rapidly. HF has a dismal prognosis, with patients dying from progressive pump failure or ventricular arrhythmias. Hypertension, which affects around 15% of the general population, is strongly associated with heart failure with 80% of HF patients having hypertension. 

PMCA1 is a member of a family of four transmembrane calcium transporters that eject calcium from the cell, but whose exact (patho)physiological function remains unknown. 

We have made the unexpected finding that PMCA1 is involved in all of the central features of heart failure: cardiomyopathy, arrhythmias and hypertension: 
? Our cardiomyocyte-specific PMCA1 knockout mice(PMCA1cko) develop severe cardiomyopathy with HF and lethal rhythm disorders. Rhythm disorders occur before ventricular dilatation suggesting a highly specific mechanism. 
? Our heterozygote global PMCA1 knockout mice(PMCA1Ht) have raised blood pressure (homozygotes are not viable).
? Three recent genome wide association studies (White, Korean and Japanese populations) by others have identified single nucleotide polymorphisms in the PMCA1 gene as the single strongest association with blood pressure variance in humans.

It is the purpose of the present programme to determine the mechanisms underlying the role of PMCA1 in heart failure and high blood pressure at the whole animal, organ as well as at the cellular/molecular level.

To this end, we will use our tissue-specific (cardiomyocyte, vascular smooth muscle) PMCA1 knockout mice as well as state-of-the-art in vivo haemodynamic, electrophysiological, functional and molecular techniques. We have 20 years of experience with the molecular biology and (patho)physiology of the plasma membrane calcium pumps; all requisite techniques are long established in our group and we are leaders in the field. This leadership has been recognised and facilitated by MRC International Appointee and programme grant funding since 2001, which has been on PMCA4, an independent isoform of the calcium pump with entirely different functions. 

This programme is at the heart of the research priorities of the MRC. Firstly, research into heart failure, ventricular arrhythmias and hypertension have been key areas of MRC funding over many years. Secondly, understanding the function of the genes underlying the genetic components of disease (physiological genomics) has been defined as a focus of the MRC (Theme 2, ?Living a long and healthy life?, ?Genetics and Disease?).</gtr:technicalSummary><gtr:fund><gtr:end>2017-01-15</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-01-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1316145</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>PMCA1 and intestin</gtr:description><gtr:id>D0418983-62C3-420A-AB91-C4C08B2A8E6F</gtr:id><gtr:impact>Ryan Z.C., Craig T.A., Filoteo A.G., Westendorf J.J., Cartwright E.J., Neyses L., Strehler E.E., Kumar R. Deletion of the intestinal
plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired
responsiveness to 1, 25-dihydroxyvitamin D3. Biochemical and Biophysical Research Communications. 2015</gtr:impact><gtr:partnerContribution>Research has been published 
Ryan Z.C., Craig T.A., Filoteo A.G., Westendorf J.J., Cartwright E.J., Neyses L., Strehler E.E., Kumar R. Deletion of the intestinal
plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired
responsiveness to 1, 25-dihydroxyvitamin D3. Biochemical and Biophysical Research Communications. 2015</gtr:partnerContribution><gtr:piContribution>PMCA1 floxed mice to be used as part of project for which grant funding has been requested. Analysis of some data which was subsequently published.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research (NIHR)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Environmental Health Sciences (NIEHS)</gtr:department><gtr:description>PMCA1 and development</gtr:description><gtr:id>1BD45A5B-7A3B-48C0-9D3A-094D6DDB1779</gtr:id><gtr:impact>-</gtr:impact><gtr:partnerContribution>Investigation of the role of PMCA1 in development</gtr:partnerContribution><gtr:piContribution>Provision of PMCA1 floxed mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>AHA Congress, Orlando</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4674ADA1-39B9-437C-9F82-D63E290C3906</gtr:id><gtr:impact>.....

recognition for the group and the University of Manchester</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview Day at Trininty High School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>103ACFEC-1949-4833-9EFA-27750B11D9B9</gtr:id><gtr:impact>....</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Body Experience</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>358E1927-985C-46AB-B30D-56463499BA81</gtr:id><gtr:impact>General public attended the workshop as part of The Body Experience at Manchester Museum entitled &amp;quot;Go with the bloodflow&amp;quot;

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A novel role for PMCA1 in cardiomyopathy and blood pressure control, Qeen Mary University, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D2D7AD4D-8E6D-4B0A-8DAC-8625BC13E5A7</gtr:id><gtr:impact>attended by medical faculty, post-graduate and undergraduate students

recognition to the group and the University of Manchester</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B4AD2EDE-631B-4479-A191-9CE71421742C</gtr:id><gtr:impact>Year 12/13 pupils attended the talk enitled &amp;quot;The cardiovascular system in health and disease&amp;quot;

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HFA Congress Belgrade</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3CA90481-0A6F-4716-A44B-341AB234ABF4</gtr:id><gtr:impact>....

recognition for the group and the University of Manchester</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Heart Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D69A410C-E9D0-4BEE-943E-2183525FF67F</gtr:id><gtr:impact>....

.....</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience placements</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A3442393-A669-4742-8AE2-5A94004874B3</gtr:id><gtr:impact>....</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AHA Basic Cardiovascular Sciences meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E217BC80-7167-48A7-AD40-D82A9B9874D7</gtr:id><gtr:impact>recognition for the University

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1235472</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A novel role for the plasma membrane calcium pump (PMCA1) in cardiomyopathy and blood pressure control</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002082</gtr:fundingRef><gtr:id>CE6C90A2-FDC0-4492-BBE0-4FD831A63401</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The mice carry a small genetic mutation (loxP) flanking a critical component of the PMCA1 gene. Upon crossing with a mouse line expressing Cre recombinase under a gene-specific promoter the genetic deletion for the isoform 1 of the plasma membrane calcium pump will occur in specific tissues or point in time. This mouse model is used to understand the role of PMCA1 in health and disease.</gtr:description><gtr:id>1462E353-76CC-4142-B791-E5FAF64ECC37</gtr:id><gtr:impact>This model is valuable for any researcher wishing to investigate the role of PMCA1 in health and disease. The impact of this model are ongoing. It was given to a reserch group in USA</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PMCA1 floxed mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The mice carry a genetic deletion for the isoform 1 of the plasma membrane calcium pump specifically in the cardiac muscle cells. This mouse model is used to understand the molecular mechanisms underlying the development and progression of cardiac hypertrophy and heart failure.</gtr:description><gtr:id>65970150-6124-40CE-86B3-59E2260BF3E4</gtr:id><gtr:impact>ongoing</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PMCA1 cardiac specific knock-out</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97647B36-644B-4DD8-B2CF-203EDCB37AB6"><gtr:id>97647B36-644B-4DD8-B2CF-203EDCB37AB6</gtr:id><gtr:title>Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump--a novel therapeutic target for contraception and malaria.</gtr:title><gtr:parentPublicationTitle>Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8a3b91614947e6fb9c73d10d48dc7fb6"><gtr:id>8a3b91614947e6fb9c73d10d48dc7fb6</gtr:id><gtr:otherNames>Mohamed TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1482-1826</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40DB495C-7723-497E-AABA-A8E44F09553E"><gtr:id>40DB495C-7723-497E-AABA-A8E44F09553E</gtr:id><gtr:title>Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2e3a8196ea0d9c6214159e5e16fd2a38"><gtr:id>2e3a8196ea0d9c6214159e5e16fd2a38</gtr:id><gtr:otherNames>Tsui H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/732A6F73-F1F0-4A14-9536-278CA286E53D"><gtr:id>732A6F73-F1F0-4A14-9536-278CA286E53D</gtr:id><gtr:title>Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cd5a2205be0823bf4a0d59146c0b92f6"><gtr:id>cd5a2205be0823bf4a0d59146c0b92f6</gtr:id><gtr:otherNames>Baggott RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E957F1D4-E17B-4FAB-A882-4FE3D36B378D"><gtr:id>E957F1D4-E17B-4FAB-A882-4FE3D36B378D</gtr:id><gtr:title>The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-a signalling in cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8a3b91614947e6fb9c73d10d48dc7fb6"><gtr:id>8a3b91614947e6fb9c73d10d48dc7fb6</gtr:id><gtr:otherNames>Mohamed TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/336FE2C9-B9D7-4699-A986-BB053868CBD8"><gtr:id>336FE2C9-B9D7-4699-A986-BB053868CBD8</gtr:id><gtr:title>Plasma membrane calcium ATPases (PMCAs) as potential targets for the treatment of essential hypertension.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7a310aa38fc07d1ed3ca2c795e1a9f84"><gtr:id>7a310aa38fc07d1ed3ca2c795e1a9f84</gtr:id><gtr:otherNames>Little R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3308B9CD-7716-47E1-A89E-52FB4260FA5B"><gtr:id>3308B9CD-7716-47E1-A89E-52FB4260FA5B</gtr:id><gtr:title>The mammalian Ste20-like kinase 2 (Mst2) modulates stress-induced cardiac hypertrophy.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/776db90b25d4f70bab385d60fac223db"><gtr:id>776db90b25d4f70bab385d60fac223db</gtr:id><gtr:otherNames>Zi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/993A83D5-39A2-48B1-8AA2-3FE64D05B7F3"><gtr:id>993A83D5-39A2-48B1-8AA2-3FE64D05B7F3</gtr:id><gtr:title>Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c3205ec97d8c1babf514ac42bf10dda"><gtr:id>2c3205ec97d8c1babf514ac42bf10dda</gtr:id><gtr:otherNames>Davies L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB5C8BC4-6560-4572-8E7C-923F37EA28CF"><gtr:id>CB5C8BC4-6560-4572-8E7C-923F37EA28CF</gtr:id><gtr:title>Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cd5a2205be0823bf4a0d59146c0b92f6"><gtr:id>cd5a2205be0823bf4a0d59146c0b92f6</gtr:id><gtr:otherNames>Baggott RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF8FA600-386B-4A84-BE02-1A77BFCC103B"><gtr:id>EF8FA600-386B-4A84-BE02-1A77BFCC103B</gtr:id><gtr:title>Role of advanced glycation end products in cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>World journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4611225f589c631efa432e133805cafc"><gtr:id>4611225f589c631efa432e133805cafc</gtr:id><gtr:otherNames>Hegab Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E662E60C-80D0-4057-9704-5C8E92FAB8C7"><gtr:id>E662E60C-80D0-4057-9704-5C8E92FAB8C7</gtr:id><gtr:title>Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a16788a08f8fbd1414624500d324155c"><gtr:id>a16788a08f8fbd1414624500d324155c</gtr:id><gtr:otherNames>Temple IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8C7AA8A9-FF5F-4FA0-901A-0A05078AC55A"><gtr:id>8C7AA8A9-FF5F-4FA0-901A-0A05078AC55A</gtr:id><gtr:title>A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.</gtr:title><gtr:parentPublicationTitle>Circulation. Heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14bc14b523f46259b756e82875d7f82"><gtr:id>c14bc14b523f46259b756e82875d7f82</gtr:id><gtr:otherNames>Liu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1941-3289</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/333AA201-0858-4888-AFA6-58209C6F5551"><gtr:id>333AA201-0858-4888-AFA6-58209C6F5551</gtr:id><gtr:title>Calcium Extrusion Pump PMCA4: A New Player in Renal Calcium Handling?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66a9038d4ff73f58094817bb96b2322c"><gtr:id>66a9038d4ff73f58094817bb96b2322c</gtr:id><gtr:otherNames>van Loon EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91BF5170-FBF0-4472-9CA8-8FB94D5C633A"><gtr:id>91BF5170-FBF0-4472-9CA8-8FB94D5C633A</gtr:id><gtr:title>Deletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1, 25-dihydroxyvitamin D3.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50fbe7f8de76145d7a1b4a2824cb5154"><gtr:id>50fbe7f8de76145d7a1b4a2824cb5154</gtr:id><gtr:otherNames>Ryan ZC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C773E68-684B-4488-85A7-D9D63BCBFA6E"><gtr:id>1C773E68-684B-4488-85A7-D9D63BCBFA6E</gtr:id><gtr:title>A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7a6273386a10a01f609cf51ebc5447f"><gtr:id>a7a6273386a10a01f609cf51ebc5447f</gtr:id><gtr:otherNames>Simon MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/739C29D5-FDF9-4DBF-A586-C578EE318A8D"><gtr:id>739C29D5-FDF9-4DBF-A586-C578EE318A8D</gtr:id><gtr:title>Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca(2+) homeostasis.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36344EDB-0CF2-450C-8FAF-73A42713BAB2"><gtr:id>36344EDB-0CF2-450C-8FAF-73A42713BAB2</gtr:id><gtr:title>Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54d763b4a0178b06a03a3c8e95a63cad"><gtr:id>54d763b4a0178b06a03a3c8e95a63cad</gtr:id><gtr:otherNames>Ulm S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B1F15A07-F929-4712-8F9C-D5221A09BEEE"><gtr:id>B1F15A07-F929-4712-8F9C-D5221A09BEEE</gtr:id><gtr:title>Pak1 is required to maintain ventricular Ca&amp;sup2;? homeostasis and electrophysiological stability through SERCA2a regulation in mice.</gtr:title><gtr:parentPublicationTitle>Circulation. Arrhythmia and electrophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-3084</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3D5A6D3-1924-4FE2-A0D5-06C3D5D185B4"><gtr:id>F3D5A6D3-1924-4FE2-A0D5-06C3D5D185B4</gtr:id><gtr:title>Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca(2+) homeostasis.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77D22C9B-B3E4-4382-9783-FBC6B76D8845"><gtr:id>77D22C9B-B3E4-4382-9783-FBC6B76D8845</gtr:id><gtr:title>Development and characterization of a novel fluorescent indicator protein PMCA4-GCaMP2 in cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8a3b91614947e6fb9c73d10d48dc7fb6"><gtr:id>8a3b91614947e6fb9c73d10d48dc7fb6</gtr:id><gtr:otherNames>Mohamed TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002082</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>